臨床試驗概論-生物醫學觀點
Clinical trials from a biomedial scientist perspective
學期
108-2
學分
2
學分
當期課號
B544
永久課號
B1123
開課單位
臨床醫學研究所
校區
陽明
類別
選修
上課時間表
| 節 | 週三 |
|---|---|
7 15:30–16:20 | 臨床試驗概論-生物醫學觀點 YR105 2 節連堂 |
8 16:30–17:20 |
* 根據陽明交大上課時間表所列
週次計畫
| 週次 | 主題 |
|---|---|
| 第 1 週 | 課程介紹- |
| 第 2 週 | Basic concepts of clinical trials |
| 第 3 週 | The story of endpoints (I): insights from the OBI-822 trial |
| 第 4 週 | The story of endpoints (II): CLEOPATRA trial |
| 第 5 週 | Subgroup analysis: IPASS trial |
| 第 6 週 | Cross over design: IMVigor211 trial |
| 第 7 週 | Ethics in clinical trials: Anil Potti |
| 第 8 週 | Red wine and clinical trials: The story of resveratrol |
| 第 9 週 | 期中考週 |
| 第 10 週 | The power of commercial marketing: PROVE-IT trial |
| 第 11 週 | The challenge of a long hypothesis: AMARANTH /DAYBREAK-ALZ |
| 第 12 週 | Surviving sepsis revisited and revisisted again: PROWESS/SHOCK |
| 第 13 週 | The wonder trial that tested non-inferiority: FISSION/NEUTRINO |
| 第 14 週 | Choosing the right opponent: KEYNOTE-040 |
| 第 15 週 | The fastest record holder: Glivec |
| 第 16 週 | Hope is lost? Olaratumumab in the ANNOUNCE trial |
| 第 17 週 | Impact of adverse effects: Sandpiper trial |
| 第 18 週 | 期末考週 |